Immunization: COVID-19 - HL7 Europe Hospital Discharge Report v1.0.0-alpha

HL7 Europe Hospital Discharge Report
1.0.0-alpha - qa-preview 150

This page is part of the HL7 Europe Hospital Discharge Report (v1.0.0-alpha: QA Preview) based on FHIR (HL7® FHIR® Standard) R4. This version is a pre-release. The current official version is 0.1.0-ballot. For a full list of available versions, see the Directory of published versions

Example Immunization: Immunization: COVID-19

Profile: Immunization (EU core)

Cross-version Extension for R5.Immunization.administeredProduct for use in FHIR R4
concept: Comirnaty 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine

status: Completed

vaccineCode: Adult B and BA.4/BA.5 lineage SARS-CoV-2 bivalent mRNA only vaccine product

patient: Fiona XXX_Swart

occurrence: 2024-11-15

location: Community Health Centre, Rome

manufacturer: BioPharma Europe Inc.

lotNumber: BATCH-COVID-2024